Zobrazeno 1 - 10
of 1 761
pro vyhledávání: '"Dörken, B"'
Autor:
Sinn, M., Nicolaou, Anna, Gebauer, B., Podrabsky, P., Seehofer, D., Ricke, J., Dörken, B., Riess, H., Hildebrandt, B.
Background Effective and tolerable chemotherapy with gemcitabine and cisplatin for advanced biliary tract cancer (BTC) has been established recently. However, overall prognosis is still poor, and additional therapeutic approaches are needed for patie
Externí odkaz:
http://hdl.handle.net/10454/7248
Autor:
Sinn, M. *, Sinn, B.V., Striefler, J.K., Lindner, J.L., Stieler, J.M., Lohneis, P., Bischoff, S., Bläker, H., Pelzer, U., Bahra, M., Dietel, M., Dörken, B., Oettle, H., Riess, H., Denkert, C.
Publikováno v:
In Annals of Oncology May 2014 25(5):1025-1032
Autor:
Meyer, A.H., Stroux, A., Lerch, K., Eucker, J., Eitle, J., Hohloch, K., Andrzejak, M., Possinger, K., Dörken, B., Pezzutto, A., Scholz, C.W. *
Publikováno v:
In Annals of Oncology January 2014 25(1):210-215
Autor:
Trappe, R. *, Hinrichs, C., Appel, U., Babel, N., Reinke, P., Neumayer, H.-H., Budde, K., Dreyling, M., Dührsen, U., Kliem, V., Schüttrumpf, S., Hauser, I.A., Mergenthaler, H.-G., Schlattmann, P., Anagnostopoulos, I., Doerken, B., Riess, H.
Publikováno v:
In American Journal of Transplantation October 2009 9(10):2331-2337
Autor:
Josting, A. *, Sieniawski, M., Glossmann, J.-P., Staak, O., Nogova, L., Peters, N., Mapara, M., Dörken, B., Ko, Y., Metzner, B., Kisro, J., Diehl, V., Engert, A.
Publikováno v:
In Annals of Oncology August 2005 16(8):1359-1365
Autor:
Josting, A. *, Rudolph, C., Mapara, M., Glossmann, J.-P., Sieber, M., Kirchner, H.H., Dörken, B., Hossfeld, D.K., Kisro, J., Metzner, B., Berdel, W.E., Diehl, V., Engert, A., Sienawski, M.
Publikováno v:
In Annals of Oncology January 2005 16(1):116-123
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Young, E, Noerenberg, D, Mansouri, L, Ljungström, V, Frick, M, Sutton, L-A, Blakemore, SJ, Galan-Sousa, J, Plevova, K, Baliakas, P, Rossi, D, Clifford, R, Roos-Weil, D, Navrkalova, V, Dörken, B, Schmitt, CA, Smedby, KE, Juliusson, G, Giacopelli, B, Blachly, JS, Belessi, C, Panagiotidis, P, Chiorazzi, N, Davi, F, Langerak, AW, Oscier, D, Schuh, A, Gaidano, G, Ghia, P, Xu, W, Fan, L, Bernard, OA, Nguyen-Khac, F, Rassenti, L, Li, J, Kipps, TJ, Stamatopoulos, K, Pospisilova, S, Zenz, T, Oakes, CC, Strefford, JC, Rosenquist, R, Damm, F
Publikováno v:
Sygma
Institutional Repository for Molecular Medicine (MDC)
Leukemia, 31(7), 1547-1554. Nature Publishing Group
Leukemia, vol 31, iss 7
Institutional Repository for Molecular Medicine (MDC)
Leukemia, 31(7), 1547-1554. Nature Publishing Group
Leukemia, vol 31, iss 7
Recurrent mutations within EGR2 were recently reported in advanced-stage chronic lymphocytic leukemia (CLL) patients and associated with a worse outcome. To study their prognostic impact, 2403 CLL patients were examined for mutations in the EGR2 hots
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::68e8440f22f726f4a7ad0c11d529803d
Publikováno v:
In European Journal of Cancer July 2003 39(11):1511-1516
Autor:
Josting, A. *, Rudolph, C., Reiser, M., Mapara, M., Sieber, M., Kirchner, H.H., Dörken, B., Hossfeld, D.K., Diehl, V., Engert, A.
Publikováno v:
In Annals of Oncology October 2002 13(10):1628-1635